(Q40568223)
Statements
1 reference
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group (English)
1 reference
Ute Rehwald
1 reference
Holger Schulz
1 reference
Marcel Reiser
1 reference
Markus Sieber
1 reference
Jan Oliver Staak
1 reference
Franck Morschhauser
1 reference
Christoph Driessen
1 reference
Thomas Rudiger
1 reference
Konrad Muller-Hermelink
1 reference
Volker Diehl
1 reference
Andreas Engert
1 reference
German Hodgkin Lymphoma Study Group (GHSG)
1 reference
1 January 2003
1 reference
1 reference
101
1 reference
2
1 reference
420-424
1 reference
Identifiers
1 reference
1 reference